These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9310284)

  • 1. High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160.
    Hocini H; Bélec L; Iscaki S; Garin B; Pillot J; Becquart P; Bomsel M
    AIDS Res Hum Retroviruses; 1997 Sep; 13(14):1179-85. PubMed ID: 9310284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV.
    Becquart P; Hocini H; Lévy M; Sépou A; Kazatchkine MD; Bélec L
    J Infect Dis; 2000 Feb; 181(2):532-9. PubMed ID: 10669336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ELISA method to measure total and specific human secretory IgA subclasses based on selective degradation by IgA1-protease.
    Hocini H; Iscaki S; Bouvet JP; Kazatchkine MD; Bélec L
    J Immunol Methods; 2000 Feb; 235(1-2):53-60. PubMed ID: 10675757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins.
    Hocini H; Bomsel M
    J Infect Dis; 1999 May; 179 Suppl 3():S448-53. PubMed ID: 10099117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmentalization of the IgG immune response to HIV-1 in breast milk.
    Becquart P; Hocini H; Garin B; Sépou A; Kazatchkine MD; Bélec L
    AIDS; 1999 Jul; 13(11):1323-31. PubMed ID: 10449284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.
    Fiore JR; Laddago V; Lepera A; La Grasta L; Di Stefano M; Saracino A; Lopalco P; Pastore G; Angarano G
    New Microbiol; 2000 Jan; 23(1):85-92. PubMed ID: 10946410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells.
    Chomont N; Hocini H; Gody JC; Bouhlal H; Becquart P; Krief-Bouillet C; Kazatchkine M; Bélec L
    Virology; 2008 Jan; 370(2):246-54. PubMed ID: 17920650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals.
    Mestecky J; Jackson S; Moldoveanu Z; Nesbit LR; Kulhavy R; Prince SJ; Sabbaj S; Mulligan MJ; Goepfert PA
    AIDS Res Hum Retroviruses; 2004 Sep; 20(9):972-88. PubMed ID: 15585085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women.
    Lu XS; Bélec L; Pillot J
    J Infect Dis; 1993 May; 167(5):1189-92. PubMed ID: 8486953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.
    Bélec L; Ghys PD; Hocini H; Nkengasong JN; Tranchot-Diallo J; Diallo MO; Ettiègne-Traore V; Maurice C; Becquart P; Matta M; Si-Mohamed A; Chomont N; Coulibaly IM; Wiktor SZ; Kazatchkine MD
    J Infect Dis; 2001 Dec; 184(11):1412-22. PubMed ID: 11709783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.
    Bélec L; Tévi-Bénissan C; Dupré T; Mohamed AS; Prazuck T; Gilquin J; Kanga JM; Pillot J
    J Clin Immunol; 1996 Jan; 16(1):12-20. PubMed ID: 8926281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum IgA subclasses and molecular forms in HIV infection: selective increases in monomer and apparent restriction of the antibody response to IgA1 antibodies mainly directed at env glycoproteins.
    Kozlowski PA; Jackson S
    AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1773-80. PubMed ID: 1457191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160.
    VanCott TC; Kaminski RW; Mascola JR; Kalyanaraman VS; Wassef NM; Alving CR; Ulrich JT; Lowell GH; Birx DL
    J Immunol; 1998 Feb; 160(4):2000-12. PubMed ID: 9469464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraepithelial cell neutralization of HIV-1 replication by IgA.
    Huang YT; Wright A; Gao X; Kulick L; Yan H; Lamm ME
    J Immunol; 2005 Apr; 174(8):4828-35. PubMed ID: 15814709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
    Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA immunity in HIV type 1-infected chimpanzees. II. Mucosal immunity.
    Black KP; Fultz PN; Girard M; Jackson S
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1273-82. PubMed ID: 9339844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals.
    Kozlowski PA; Chen D; Eldridge JH; Jackson S
    AIDS Res Hum Retroviruses; 1994 Jul; 10(7):813-22. PubMed ID: 7986587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1.
    Alfsen A; Iniguez P; Bouguyon E; Bomsel M
    J Immunol; 2001 May; 166(10):6257-65. PubMed ID: 11342649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects.
    Devito C; Hinkula J; Kaul R; Kimani J; Kiama P; Lopalco L; Barass C; Piconi S; Trabattoni D; Bwayo JJ; Plummer F; Clerici M; Broliden K
    J Acquir Immune Defic Syndr; 2002 Aug; 30(4):413-20. PubMed ID: 12138348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal mucosal immunoglobulins during human immunodeficiency virus type 1 infection.
    Janoff EN; Jackson S; Wahl SM; Thomas K; Peterman JH; Smith PD
    J Infect Dis; 1994 Aug; 170(2):299-307. PubMed ID: 8035014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.